FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roscoe Morton

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Avima Ruder; Paul A Schulte; Patricia A Stewart; Martha Waters; James H Yiin; Mary Ann Butler; Geoffrey M Calvert; Tania Carreon; Karen E Davis-King; Misty J Hein; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman
The Upper Midwest Health Study: gliomas and occupational exposure to chlorinated solvents.
Avima Ruder; Paul A Schulte; Kathleen M Waters; Martha Waters; Mary Ann Butler; Geoffrey M Calvert; Tania Carreon; Karen E Davis-King; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman
The Upper Midwest Health Study: industry and occupation of glioma cases and controls.
James H Yiin; Mary Ann Butler; Geoffrey M Calvert; Tania Carreon; Karen E Davis-King; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman; Avima Ruder; Paul A Schulte; Patricia A Stewart; Martha Waters
The Upper Midwest Health Study: a case-control study of pesticide applicators and risk of glioma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roscoe Morton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Avima Ruder; Paul A Schulte; Patricia A Stewart; Martha Waters; James H Yiin; Mary Ann Butler; Geoffrey M Calvert; Tania Carreon; Karen E Davis-King; Misty J Hein; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman
The Upper Midwest Health Study: gliomas and occupational exposure to chlorinated solvents.
Occupational and environmental medicine 2013;70(2):73-80.
2012: Avima Ruder; Paul A Schulte; Kathleen M Waters; Martha Waters; Mary Ann Butler; Geoffrey M Calvert; Tania Carreon; Karen E Davis-King; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman
The Upper Midwest Health Study: industry and occupation of glioma cases and controls.
American journal of industrial medicine 2012;55(9):747-55.
2012: James H Yiin; Mary Ann Butler; Geoffrey M Calvert; Tania Carreon; Karen E Davis-King; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman; Avima Ruder; Paul A Schulte; Patricia A Stewart; Martha Waters
The Upper Midwest Health Study: a case-control study of pesticide applicators and risk of glioma.
Environmental health : a global access science source 2012;11():39.
2011: Nadia N Laack; Roscoe F Morton; Judith Rich O'Fallon; Brian Patrick O'Neill; Eduardo R Pajon; Bernd W Scheithauer; Harold E Windschitl; Karla V Ballman; Paul D Brown; Xiomara W Carrero; Joseph P Colgan; Tom R Fitch; Mark R Gilbert; Thomas M Habermann; Roland B Hawkins; Paul J Kurtin
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.
International journal of radiation oncology, biology, physics 2011;81(2):476-82.
2010: Kurt A Jaeckle; Karla V Ballman; Caterina Giannini; Paula J Schomberg; Matthew M Ames; Joel M Reid; Renee M McGovern; Stephanie L Safgren; Evanthia Galanis; Joon H Uhm; Paul D Brown; Julie E Hammack; Robert Arusell; Daniel A Nikcevich; Roscoe F Morton; Donald B Wender; Jan C Buckner
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.
Journal of neuro-oncology 2010;99(1):73-80.
2010: Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3227-33.
2009: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Erin Green; Hanna Sanoff; howard mcleod; Jan Buckner
NCCTG Study N9741: leveraging learning from an NCI Cooperative Group phase III trial.
The oncologist 2009;14(10):970-8.
2009: Avima Ruder; Tania Carreon; Mary Ann Butler; Geoffrey M Calvert; Karen E Davis-King; Martha Waters; Paul A Schulte; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman
Exposure to farm crops, livestock, and farm tasks and risk of glioma: the Upper Midwest Health Study.
American journal of epidemiology 2009;169(12):1479-91.
2009: Carmen J Allegra; J Milburn Jessup; Mark R Somerfield; Stanley R Hamilton; Elizabeth H Hammond; Daniel F Hayes; Pamela K McAllister; Roscoe F Morton; Richard L Schilsky
American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):2091-6.
2009: Roscoe F Morton; Elizabeth H Hammond
ASCO Provisional Clinical Opinion: KRAS, Cetuximab, and Panitumumab-Clinical Implications in Colorectal Cancer.
Journal of oncology practice / American Society of Clinical Oncology 2009;5(2):71-2.
2009: Domingo G Perez; Vera J Suman; Tom R Fitch; Thomas Amatruda; Roscoe F Morton; Shamim Z Jilani; Costas L Constantinou; James R Egner; Lisa A Kottschade; Svetomir N Markovic
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.
Cancer 2009;115(1):119-27.
2009: Alvaro Moreno-Aspitia; Roscoe F Morton; David W Hillman; Wilma L Lingle; Kendrith M Rowland; Martin Wiesenfeld; Patrick J Flynn; Tom R Fitch; Edith A Perez
Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):11-5.
2008: Hanna Sanoff; Daniel J Sargent; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5721-7.
2008: Svetomir N Markovic; Vera J Suman; Wendy K Nevala; Louis Geeraerts; Edward T. Creagan; Lori A Erickson; Kendrith M Rowland; Roscoe F Morton; William L Horvath; Mark R Pittelkow
A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study.
American journal of clinical oncology 2008;31(6):573-9.
2008: Paul D. Brown; Sunil Krishnan; Jann N. Sarkaria; Wenting Wu; Kurt A Jaeckle; Joon H Uhm; Francois J Geoffroy; Robert M Arusell; Gaspar Kitange; Robert B Jenkins; John W Kugler; Roscoe F Morton; Kendrith M Rowland; Paul Mischel; William H Yong; Bernd W Scheithauer; David Schiff; Caterina Giannini; Jan C Buckner
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5603-9.
2008: Stephen M Ansell; David J Inwards; Kendrith M Rowland; Patrick J Flynn; Roscoe F Morton; Dennis F Moore; Scott H Kaufmann; Irene M Ghobrial; Paul J Kurtin; Matthew Maurer; Cristine Allmer; Thomas E Witzig
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.
Cancer 2008;113(3):508-14.
2008: David J Inwards; Paul A. Fishkin; David W Hillman; David W Brown; Stephen M Ansell; Paul J Kurtin; Rafael Fonseca; Roscoe F Morton; Michael H Veeder; Thomas E Witzig
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group.
Cancer 2008;113(1):108-16.
2007: Grace K Dy; James E Krook; Erin M Green; Daniel J Sargent; Thierry Delaunoit; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Barbara A Pockaj; Robert P Sticca; Steven R Alberts; Henry C Pitot; Richard M Goldberg
Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3469-74.
2007: Amanda C Ashley; Daniel J Sargent; Steven R Alberts; Axel Grothey; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
Cancer 2007;110(3):670-7.
2006: Avima Ruder; Martha Waters; Tania Carreon; Mary Ann Butler; Karen E Davis-King; Geoffrey M Calvert; Paul A Schulte; Elizabeth M Ward; L Barbara Connally; J Lu; D Wall; Z Zivkovich; Ellen Heineman; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman
The Upper Midwest Health Study: a case-control study of primary intracranial gliomas in farm and rural residents.
Journal of agricultural safety and health 2006;12(4):255-74.
2006: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven Alberts
Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3347-53.
2006: Michael J O'Connell; Daniel J Sargent; Harold E Windschitl; Lois Shepherd; Michelle R Mahoney; James E Krook; Sandra Rayson; Roscoe F Morton; Kendrith M Rowland; John W Kugler
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.
Clinical colorectal cancer 2006;6(2):133-9.
2006: Matthew M Clark; Richard D Hurt; Ivana T Croghan; Christi A Patten; Paul J Novotny; Jeff A Sloan; Shaker R Dakhil; Gary A Croghan; Edward J Wos; Kendrith M Rowland; Albert M Bernath; Roscoe F Morton; Sachdex P Thomas; Loren K Tschetter; Stewart Garneau; Philip J Stella; Larry P Ebbert; Donald B Wender; Charles L Loprinzi
The prevalence of weight concerns in a smoking abstinence clinical trial.
Addictive behaviors 2006;31(7):1144-52.
2006: Kostandinos Sideras; Paul L Schaefer; Scott H Okuno; Jeff A Sloan; Leila Kutteh; Tom R Fitch; Shaker R Dakhil; Ralph Levitt; Steven R Alberts; Roscoe F Morton; Kendrith M Rowland; Paul J Novotny; Charles L Loprinzi
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.
Mayo Clinic proceedings. Mayo Clinic 2006;81(6):758-67.
2005: Grace K Dy; A A Miller; Sumithra J Mandrekar; M-C Aubry; R M Langdon; Roscoe F Morton; S E Schild; James R Jett; Alex A. Adjei
A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1811-6.
2005: Steven R Alberts; Nathan R Foster; Roscoe F Morton; J Kugler; Paul Schaefer; Martin Wiesenfeld; Tom R Fitch; P Steen; George P Kim; S Gill
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1654-61.
2005: Evanthia C Galanis; Jan C Buckner; Matthew J Maurer; Jeffrey I Kreisberg; Karla V Ballman; Joseph P Boni; Josep M Peralba; Robert B Jenkins; Shaker R Dakhil; Roscoe F Morton; Kurt A Jaeckle; Bernd W Scheithauer; Janet Dancey; Manuel Hidalgo; Daniel J Walsh
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(23):5294-304.
2005: Thomas E Witzig; Susan M Geyer; Irene M Ghobrial; David J Inwards; Rafael Fonseca; Paul J Kurtin; Stephen M Ansell; Ronnie F Luyun; Patrick J Flynn; Roscoe F Morton; Shaker R Dakhil; Howard Gross; Scott H Kaufmann
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(23):5347-56.
2005: Jeffrey A Meyerhardt; Jeffrey A Sloan; Daniel J Sargent; Richard M Goldberg; Michael Pollak; Roscoe F Morton; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Charlie S Fuchs
Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1402-10.
2005: Tania Carreon; Mary Ann Butler; Avima Ruder; Martha Waters; Karen E Davis-King; Geoffrey M Calvert; Paul A Schulte; Barbara Connally; Elizabeth M Ward; Wayne T Sanderson; Ellen Heineman; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman; Glenn Talaska
Gliomas and farm pesticide exposure in women: the Upper Midwest Health Study.
Environmental health perspectives 2005;113(5):546-51.
2005: Thomas E Witzig; Peter T Silberstein; Charles L Loprinzi; Jeff A Sloan; Paul J Novotny; James A Mailliard; Kendrith M Rowland; Steven R Alberts; James E Krook; Ralph Levitt; Roscoe F Morton
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2606-17.
2005: Thierry Delaunoit; Steven R Alberts; Daniel J Sargent; Erin Green; Richard M Goldberg; James E Krook; C Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Roscoe F Morton; Brian P Findlay
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(3):425-9.
2004: Avima Ruder; Martha Waters; Mary Ann Butler; Tania Carreon; Geoffrey M Calvert; Karen E Davis-King; Paul A Schulte; Wayne T Sanderson; Elizabeth M Ward; L Barbara Connally; Ellen Heineman; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman; Glenn Talaska
Gliomas and farm pesticide exposure in men: the upper midwest health study.
Archives of environmental health 2004;59(12):650-7.
2004: Thierry Delaunoit; Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Brian P Findlay; Sachdev P Thomas; Muhammad Salim; Paul L Schaefer; Philip J Stella; Erin Green; James A Mailliard
Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.
Cancer 2004;101(10):2170-6.
2004: Kui Huang; Elizabeth A Whelan; Avima Ruder; Elizabeth M Ward; james deddens; Karen E Davis-King; Tania Carreon; Martha Waters; Mary Ann Butler; Geoffrey M Calvert; Paul A Schulte; Zachary Zivkovich; Ellen Heineman; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman
Reproductive factors and risk of glioma in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(10):1583-8.
2004: Aminah Jatoi; Nathan Foster; P Johnson; George G Klee; J F Quevedo; Roscoe F Morton; Suresh Nair; Carl G Kardinal; James A Mailliard
Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment Group.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2004;17(4):292-6.
2004: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven R Alberts
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):23-30.
2003: James R Jett; Alan K Hatfield; Shauna Hillman; Michael D Bauman; James A Mailliard; John W Kugler; Roscoe F Morton; Randolph S Marks; Ralph Levitt
Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Cancer 2003;97(10):2498-503.
2003: Richard D Hurt; James E Krook; Ivana T Croghan; Charles L Loprinzi; Jeff A Sloan; Paul J Novotny; Carl G Kardinal; James A Knost; Maria Tria Tirona; Ferdinand K Addo; Roscoe F Morton; John C Michalak; Paul L Schaefer; Patricia A Porter; Philip J Stella
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):914-20.
2002: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Michelle R Mahoney; James E Krook; Michael J O'Connell
Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4591-6.
2002: Aminah Jatoi; Maria Tria Tirona; Stephen S Cha; Steven R Alberts; Kendrith M Rowland; Roscoe F Morton; Suresh Nair; Carl G Kardinal; Philip J Stella; James A Mailliard; Daniel Sargen; Richard M Goldberg
A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia.
International journal of gastrointestinal cancer 2002;32(2-3):115-23.
2002: Steven R Alberts; Paul A. Fishkin; Lawrence J Burgart; Peter J Cera; Michelle R Mahoney; Roscoe F Morton; Patricia A Johnson; Suresh Nair; Richard M Goldberg
CPT-11 for bile-duct and gallbladder carcinoma: a phase II North Central Cancer Treatment Group (NCCTG) study.
International journal of gastrointestinal cancer 2002;32(2-3):107-14.
2001: Bobbie S Gostout; Lynn C Hartmann; Vera J Suman; Nancy E Fay; J A Jefferies; Roscoe F Morton; Thomas A Gaffey; Gist Henry Farr; Loren K Tschetter; Samir Abu-Ghazaleh; Mary M Gallenberg; Alan K Hatfield
A randomized trial of interferon-alpha in cervical dysplasia.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2001;74(2):207-10.
2001: Jan C Buckner; Paula J Schomberg; William L McGinnis; Terrence L Cascino; Bernd W Scheithauer; Judith R O'Fallon; Roscoe F Morton; Steven A Kuross; James A Mailliard; Alan K Hatfield; J T Cole; P D Steen; Albert M Bernath
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
Cancer 2001;92(2):420-33.
2000: S V Rajkumar; Joel M Reid; P J Novotny; Stephanie L Safgren; B W Scheithauer; P S Johnson; S Nair; Roscoe F Morton; A K Hatfield; James E Krook; Matthew M Ames; Jan C Buckner
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma.
Journal of neuro-oncology 2000;49(3):255-61.
2000: Evanthia C Galanis; Jan C Buckner; Paul J Novotny; Roscoe F Morton; William L McGinnis; Robert P Dinapoli; Paula J Schomberg; Judith R O'Fallon
Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas.
Journal of neurosurgery 2000;93(2):201-7.
1999: Arie Perry; Robert B Jenkins; Judith R O'Fallon; Paul L Schaefer; David W Kimmel; Michelle R Mahoney; Bernd W Scheithauer; S M Smith; E M Hill; T J Sebo; Ralph Levitt; James E Krook; Loren K Tschetter; Roscoe F Morton; Jan C Buckner
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression.
Cancer 1999;86(4):672-83.
1999: SV Rajkumar; Patrick A Burch; Suresh Nair; Robert P Dinapoli; Bernd W Scheithauer; Judith R O'Fallon; P S Etzell; J M Leitch; Roscoe F Morton; Randolph S Marks
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma.
American journal of clinical oncology 1999;22(2):168-71.
1999: RF Marschke; JP Grill; Jeff A Sloan; Donald B Wender; Ralph Levitt; James A Mailliard; JB Gerstner; C Ghosh; Roscoe F Morton; James R Jett
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer.
American journal of clinical oncology 1999;22(1):15-7.
1998: Evanthia C Galanis; Jan C Buckner; Patrick A Burch; Paul L Schaefer; Robert P Dinapoli; Paul J Novotny; Bernd W Scheithauer; Kendrith M Rowland; Allen M Vukov; James A Mailliard; Roscoe F Morton
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):2953-8.
1997: T E Elliott; Robert P Dinapoli; Judith R O'Fallon; James E Krook; John D Earle; Roscoe F Morton; R Levitt; Loren K Tschetter; Bernd W Scheithauer; DM Pfeifle; D I Twito; Robert A Nelimark
Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.
Journal of neuro-oncology 1997;33(3):239-50.
1996: Terrence L Cascino; Michael H Veeder; Jan C Buckner; Judith R O'Fallon; M Wiesenfeld; Ralph Levitt; Richard M Goldberg; Steven A Kuross; Roscoe F Morton; Bernd W Scheithauer
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor.
Journal of neuro-oncology 1996;30(3):243-6.
1996: Joseph Rubin; J G Gallagher; Georgene Schroeder; A J Schutt; Robert J Dalton; John W Kugler; Roscoe F Morton; James A Mailliard; Patrick A Burch
Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma.
Cancer 1996;78(9):1888-91.
1996: Charles L Loprinzi; E M Messing; Judith R O'Fallon; M A Poon; R R Love; Susan K Quella; D L Trump; Roscoe F Morton; Paul J Novotny
Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(5):371-4.
1996: James A Martenson; G Hyland; C G Moertel; James A Mailliard; Judith R O'Fallon; R T Collins; Roscoe F Morton; H H Tewfik; R L Moore; A R Frank; R E Urias; R L Deming
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial.
International journal of radiation oncology, biology, physics 1996;35(2):299-303.
1995: Edward T. Creagan; Robert J Dalton; D L Ahmann; S H Jung; Roscoe F Morton; R M Langdon; J Kugler; L J Rodrigue
Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2776-83.
1995: Louis Letendre; Ralph Levitt; R V Pierre; Georgene Schroeder; J A Krook; J E Mailliard; Roscoe F Morton; Loren K Tschetter
Myelodysplastic syndrome treatment with danazol and cis-retinoic acid.
American journal of hematology 1995;48(4):233-6.
1995: Ralph Levitt; Jan C Buckner; Terrence L Cascino; Patrick A Burch; Roscoe F Morton; M W Westberg; Richard M Goldberg; J G Gallagher; Judith R O'Fallon; B W Scheithauer
Phase II study of amonafide in patients with recurrent glioma.
Journal of neuro-oncology 1995;23(1):87-93.
1994: Charles L Loprinzi; A M Bernath; Daniel J Schaid; J A Malliard; L M Athmann; John C Michalak; Loren K Tschetter; Alan K Hatfield; Roscoe F Morton
Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Oncology 1994;51 Suppl 1():2-7.
1994: M Wiesenfeld; J R Jett; J Q Su; T A Braich; Carl G Kardinal; James A Mailliard; Michael H Veeder; Roscoe F Morton; John C Michalak
Phase II trial of edatrexate in small cell lung cancer.
Cancer 1994;73(4):1189-93.
1993: Charles L Loprinzi; John C Michalak; Daniel J Schaid; James A Mailliard; L M Athmann; Richard M Goldberg; Loren K Tschetter; Alan K Hatfield; Roscoe F Morton
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):762-7.
1992: J A Laurie; Richard G Hahn; Terry M Therneau; S R Patel; James A Mailliard; Harold E Windschitl; D I Twito; Roscoe F Morton; James E Krook
Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil.
Cancer 1992;69(6):1440-4.
1991: H J LONG; H S Wieand; J F Foley; R D Niedringhaus; J A Laurie; Roscoe F Morton; Richard M Goldberg; James A Mailliard; G D Malkasian; J H Edmonson
Phase II evaluation of menogaril in patients with advanced cervical carcinoma. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.
Investigational new drugs 1991;9(4):349-51.
1991: Roscoe F Morton; James R Jett; W L McGinnis; J D Earle; Terry M Therneau; James E Krook; T E Elliott; James A Mailliard; R A Nelimark; A W Maksymiuk
Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.
Annals of internal medicine 1991;115(9):681-6.
1991: Roscoe F Morton; Edward T. Creagan; Daniel J Schaid; Carl G Kardinal; G W McCormack; M S McHale; M Wiesenfeld
Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanoma.
American journal of clinical oncology 1991;14(2):152-5.
1989: L K Everson; James R Jett; Judith R O'Fallon; James E Krook; Robert J Dalton; James A Mailliard; Loren K Tschetter; S A Cullinan; JB Gerstner; Roscoe F Morton
Alternating chemotherapy with or without VP-16 in extensive-stage small-cell lung cancer.
American journal of clinical oncology 1989;12(4):339-44.
1988: Terrence L Cascino; L D Brown; Roscoe F Morton; L K Everson; RF Marschke; Robert P Dinapoli; Judith R O'Fallon
Evaluation of fludarabine phosphate in patients with recurrent glioma.
American journal of clinical oncology 1988;11(5):586-8.
1987: Roscoe F Morton; Edward T. Creagan; S A Cullinan; James A Mailliard; Larry P Ebbert; Michael H Veeder; M Chang
Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(7):1078-82.
1987: Roscoe F Morton; Edward T. Creagan; Michael H Veeder; D L Elson; J A Laurie; R A Nelimark; M N Chang
Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanoma.
Cancer treatment reports 1987;71(4):429-30.